논문 목록
6건 · 최신순-
An Evaluation of VYC-17.5L for the Treatment of Marionette Lines: A Prospective, Open-Label, Postmarketing Study.
[BACKGROUND] Marionette lines are a feature of the aging face, descending from the oral commissures towards the jaw. VYC-17.5 L is a dermal filler that contains 17.5 mg/mL of hyaluronic acid (HA) and lidocaine (3 mg/mL); it is intended for …
-
A Prospective, Open-Label, Post Marketing Study of the Safety and Effectiveness of a Hyaluronic Acid and Calcium Hydroxyapatite Hybrid Injectable.
[BACKGROUND] HA-CaHA is a hybrid injectable combining hyaluronic acid and calcium hydroxyapatite for dual-mode facial soft tissue augmentation. HA-CaHA-L includes 0.3% lidocaine HCL. [OBJECTIVE] This prospective, open-label study evaluated…
-
A Retrospective Analysis of Safety in Participants Treated with a Hybrid Hyaluronic Acid and Calcium Hydroxyapatite Filler.
[BACKGROUND] Limited long-term safety data are published on HA/CaHA/L, a hybrid dermal filler combining hyaluronic acid (HA), calcium hydroxyapatite (CaHA), and lidocaine (L). [METHODS] This retrospective multicenter study assessed treatme…
-
A Prospective, Open-Label, Multicenter, Real-World Study of VYC-17.5L Hyaluronic Acid Dermal Filler in the Lips.
[BACKGROUND] Hyaluronic acid (HA) injectable gels are used to define, enhance, and volumize facial regions, such as the lips, a common treatment area. [OBJECTIVES] To evaluate the effectiveness and safety of the HA injectable gel Juvéderm …
-
Improvement of Radial Cheek Lines With Hyaluronic Acid-Based Dermal Filler VYC-17.5L: Results of the BEAM Study.
[BACKGROUND] Radial cheek lines (RCL) may convey an older, potentially less attractive appearance. [OBJECTIVE] To evaluate the effectiveness of hyaluronic acid-based dermal filler VYC-17.5L for correcting RCL. [MATERIALS AND METHODS] Fift…
-
A Prospective, Open-Label, Observational, Postmarket Study Evaluating VYC-17.5L for the Correction of Moderate to Severe Nasolabial Folds Over 12 Months.
[BACKGROUND] VYC-17.5L (17.5 mg/mL hyaluronic acid, 0.3% lidocaine) is a dermal filler intended for deep dermis injection for the treatment of skin depressions. [OBJECTIVE] To evaluate 12-month effectiveness and safety of VYC-17.5L for the…